FR2647346B1 - Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament - Google Patents
Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicamentInfo
- Publication number
- FR2647346B1 FR2647346B1 FR8907008A FR8907008A FR2647346B1 FR 2647346 B1 FR2647346 B1 FR 2647346B1 FR 8907008 A FR8907008 A FR 8907008A FR 8907008 A FR8907008 A FR 8907008A FR 2647346 B1 FR2647346 B1 FR 2647346B1
- Authority
- FR
- France
- Prior art keywords
- compound
- medicament
- stabilized
- preparing
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8907008A FR2647346B1 (fr) | 1989-05-29 | 1989-05-29 | Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8907008A FR2647346B1 (fr) | 1989-05-29 | 1989-05-29 | Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2647346A1 FR2647346A1 (fr) | 1990-11-30 |
FR2647346B1 true FR2647346B1 (fr) | 1991-09-06 |
Family
ID=9382096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8907008A Expired - Fee Related FR2647346B1 (fr) | 1989-05-29 | 1989-05-29 | Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2647346B1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8778922B2 (en) | 2009-01-08 | 2014-07-15 | Lipocine Inc. | Steroidal compositions |
US9205057B2 (en) | 2010-11-30 | 2015-12-08 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033549A2 (fr) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865848A (en) * | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
-
1989
- 1989-05-29 FR FR8907008A patent/FR2647346B1/fr not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8778922B2 (en) | 2009-01-08 | 2014-07-15 | Lipocine Inc. | Steroidal compositions |
US8865695B2 (en) | 2009-01-08 | 2014-10-21 | Lipocine Inc. | Steroidal compositions |
US9949985B2 (en) | 2010-11-30 | 2018-04-24 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US10799513B2 (en) | 2010-11-30 | 2020-10-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9480690B2 (en) | 2010-11-30 | 2016-11-01 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US11433083B2 (en) | 2010-11-30 | 2022-09-06 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9757390B2 (en) | 2010-11-30 | 2017-09-12 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9943527B2 (en) | 2010-11-30 | 2018-04-17 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9205057B2 (en) | 2010-11-30 | 2015-12-08 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US10226473B2 (en) | 2010-11-30 | 2019-03-12 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US10716794B2 (en) | 2010-11-30 | 2020-07-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US10881671B2 (en) | 2010-11-30 | 2021-01-05 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US10973833B2 (en) | 2010-11-30 | 2021-04-13 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US11364249B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US11364250B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Also Published As
Publication number | Publication date |
---|---|
FR2647346A1 (fr) | 1990-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86182A (en) | Process for the preparation of 3-pyrrolidinylthio-1-azabicyclo]3,2,o"hept-2-ene-2-carboxylic acid compounds | |
MA21962A1 (fr) | Procede pour la preparation d'inhibiteurs de proteass retrovirales . | |
IL95946A0 (en) | Preparation of tetrabromo-4,4'-alkylidenediphenols | |
EP0249530A3 (en) | Process for the preparation of glyoxal monoacetals | |
HU901428D0 (en) | Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives | |
FR2647346B1 (fr) | Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament | |
FI894546A (fi) | Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi | |
OA07984A (fr) | Procédé stéréocontrolé de préparation d'acetoxyazetidione. | |
OA07202A (fr) | Procédé pour la préparation de l'urée | |
NO176098C (no) | Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner | |
FR2630735B1 (fr) | Procede de preparations d'halogenophenols | |
EP0389110A3 (en) | Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine | |
FR2453184B1 (fr) | Composant de titane catalytique, procede pour la preparation de celui-ci et procede de polymerisation d'alcenes-1 en utilisant un composant de titane de ce type | |
FR2633273B1 (fr) | Procede de preparation de tetraflurorure d'uranium | |
FR2619676B3 (fr) | Pulverisateur, notamment pour l'agriculture | |
IL92465A0 (en) | Process for the preparation of 4,4'-dibromodiphenylether | |
EG18954A (en) | New bronchospasmolytic compounds and process for their preparation | |
PT81976A (en) | Process for the preparation of a new agrochemical named "substance no. 51262" | |
FR2540492B1 (fr) | Procede pour la preparation d'oxime ethers basiques | |
EP0253413A3 (en) | New antibiotics called "mureidomycins a, b, c and d" a process for their preparation and their therapeutic use | |
FR2630741B1 (fr) | Procede de preparation d'acryloyloxyethoxymethyl-melamines | |
FR2634765B1 (fr) | Procede pour la preparation de levo- et de dextro-dropropizine | |
PT85518A (en) | Process for the preparation of antibacterial 7-oxo-4-thia-1-aza-bicyclo ]3.2.o" hept-2-ene derivatives | |
DE3666804D1 (en) | Process for the preparation of 4,4'-dihydroxydiphenyl ether | |
OA07201A (fr) | Procédé pour la préparation de l'urée . |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |